Is Cryo-Cell International, Inc. (CCEL) a Buy, Sell, or Hold?
AMEX : CCEL
Cryo-Cell International, Inc. — News
$3.6 USD
$0.03 (0.84%)
- Volume
- 6.62K
- Average Volume
- 9.35K
- Market Capitalization
- $29.03M
- P/E Ratio
- -12.24
- Dividend Yield
- 0.00%
- Price Target
- $8.50
- Year High
- $5.01
- Year Low
- $2.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.71
| Source | Headline |
|---|---|
|
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2026. Financial Results Revenue The revenues for the second quarter of fiscal 2026 were $7.8 million compared to $7.9 million for the second quarter of fiscal 2025, a 2% decrease. The revenues for the second quarter of fiscal 2026 consisted of $7.7. businesswire.com - 2026-07-15 16:30:00 |
